Advertisement
Interested parties may access the presentation by visiting the Company'scorporate website at www.ert.com. The webcast may also be accessed athttp://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=ERES&item_id=2021116.The webcast will be available via replay for 90 days.
Advertisement
Based in Philadelphia, PA, eResearchTechnology, Inc. (http://www.eRT.com)is a provider of technology and services to the pharmaceutical, biotechnologyand medical device industries on a global basis. The company is a marketleader in providing centralized core-diagnostic electrocardiographic (ECG)technology and services to evaluate cardiac safety in clinical development.The company is also a leader in providing technology and services tostreamline the clinical trials process by enabling its customers to automatethe collection, analysis, and distribution of clinical data in all phases ofclinical development.
Statements included in this release may constitute forward-lookingstatements within the meaning of the Private Securities Litigation Reform Actof 1995. Such statements, including but not limited to 2008 financialguidance, involve a number of risks and uncertainties such as the company'sability to obtain new contracts and accurately estimate net revenues due touncertain regulatory guidance, variability in size, scope and duration ofprojects, and internal issues at the sponsoring client, integration ofacquisitions, competitive factors, technological development, and marketdemand. As a result, actual results may differ materially from any financialoutlooks stated herein. Further information on potential factors that couldaffect the company's financial results can be found in the company's Reportson Form 10-K and 10-Q filed with the Securities and Exchange Commission. Thecompany undertakes no obligation to publicly update any forward-lookingstatement, whether as a result of new information, future events or otherwise.
SOURCE eResearchTechnology, Inc.
